v3.26.1
Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income - EUR (€)
€ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income        
Revenue € 8,759 € 3,817 € 10,792 € 8,336
Other income   158   380
Research and development costs (12,667) (11,408) (24,497) (23,731)
General and administrative costs (4,914) (4,816) (8,766) (8,050)
Total operating costs (17,581) (16,224) (33,263) (31,781)
Operating result (8,822) (12,249) (22,471) (23,065)
Finance income and expense 152 192 364 647
Results related to financial liabilities measured at fair value through profit or loss (33) (104) 21 178
Result before corporate income taxes (8,703) (12,161) (22,086) (22,240)
Income taxes (25) (18) (25) (18)
Result for the period (8,728) (12,179) (22,111) (22,258)
Other comprehensive income (foreign exchange differences on foreign operation) 48 (682) 227 (1,053)
Total comprehensive income (8,680) (12,861) (21,884) (23,311)
Result attributable to        
Owners of the Company (8,728) (12,179) (22,111) (22,258)
Total comprehensive loss attributable to        
Owners of the Company € (8,680) € (12,861) € (21,884) € (23,311)
Share information        
Weighted average number of shares outstanding (basic) [1] 109,958,613 105,343,897 107,673,118 105,320,495
Weighted average number of shares outstanding (diluted) [1] 109,958,613 105,343,897 107,673,118 105,320,495
Earnings per share attributable to owners of the Company (Euro per share)        
Basic loss per share [1] € (0.08) € (0.12) € (0.21) € (0.21)
Diluted loss per share [1] € (0.08) € (0.12) € (0.21) € (0.21)
[1] For these periods the potential exercise of share options is not included in the diluted earnings per share as the Company was loss-making. Due to the anti-dilutive nature of the outstanding options, basic and diluted earnings per share are equal.